AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Dec 16 2021
Headline Roundup
COVID-19 Cases Rise in Several Countries as Omicron Spreads
The U.S., the U.K. and other countries have seen spikes in COVID-19 cases over the past week.
U.S. states with rising cases included New York and New Jersey, where CDC data said the milder but more vaccine resistant Omicron variant is spreading. While some highly-vaccinated states saw significant outbreaks, a Forbes (Center) report said, they still fared better on hospitalizations and
Forbes New York Times (News) New York Post (News)Think Tank / Policy Group
Prager University
Learn the AllSides media bias rating of PragerU. AllSides has rated the bias of hundreds of media outlets, sources and writers.
Apr 27 2021
Headline Roundup
More Than 5 Million Americans Missed Second Vaccine Dose
Nearly eight percent of the people who received their first COVID-19 vaccine dose — roughly 5 million Americans — didn't return for the second shot, according to a New York Times report. The report cites the most recent data from the Centers for Disease Control and Prevention, which only included people who got their first Moderna dose by March 7 or first Pfizer dose by March 14. Each of these
International Business Times New York Times (News) Newsmax (News)Sep 13 2021
Headline Roundup
Top FDA and WHO Scientists Call COVID-19 Booster Shots Unnecessary For Most Americans At This Time
An international group of scientists published a paper Monday that suggests more scientific evidence is needed to justify giving booster shots to most Americans at this time. Co-authors included Marion Gruber and Phil Krause, two senior FDA officials who are leaving the organization later this fall over frustrations with the Biden administration’s "premature" booster plan, along with several
Politico Newsmax (News) STATJan 29 2021
Headline Roundup
Johnson & Johnson Announces 1-Shot Vaccine is 66% Effective Against Moderate to Severe COVID-19
Johnson & Johnson announced Friday that its coronavirus vaccine, the only single-dose vaccine to pass phase 3 clinical trials, was on average 66% effective against moderate to severe illness, 85% effective against severe infections and 100% effective against hospitalizations and death. Effectiveness varied regionally, however; effectiveness against moderate illness was 72% in the U.S., 66
New York Times (News) NPR (Online News) National Review (News)Mar 30 2022
Headline Roundup
Biden Receives Second Booster Shot, Calls for Additional COVID-19 Funding
President Joe Biden received a second booster dose of the COVID-19 vaccine on camera on Wednesday after calling upon Congress to approve additional COVID-19 funds.
Biden said that without additional funding, his administration would not be able to ensure additional booster shots “are available, free, easily accessible for all Americans,” adding, “This isn't partisan, it's medicine.”
Associated Press Fact Check CNBC New York Post (News)